|Department||Department of Pharmacology and Toxicology|
|Qualifications||MSc (Biological chemistry and drug discovery)|
|Research summary||Design and synthesis of ligands for cannabinoid type 2 receptors|
ResearchAs part of the medicinal chemistry group in Dr Andrea Vernall's lab in the School of Pharmacy my PhD focuses on the design and synthesis of flourescent ligands which are selective for cannabinoid type 2 receptor.
Liddle, I., Glass, M., Tyndall, J. D. A., & Vernall, A. J. (2022). Covalent cannabinoid receptor ligands: Structural insight and selectivity challenges. RSC Medicinal Chemistry. Advance online publication. doi: 10.1039/D2MD00006G
Singh, S., Liddle, I., Macdonald, C., Tyndall, J. D. A., Glass, M., & Vernall, A. (2021). Development of chromenopyrazole-based selective cannabinoid 2 receptor agonists. Australian Journal of Chemistry, 74, 433-442. doi: 10.1071/CH20263